CFN Exclusive Interview: MedMen Becomes Canada’s Next Billion Dollar Cannabis Listing
Ryan Allway
May 29th, 2018
Exclusive, News, Top News
MedMen Enterprises (CSE: MMEN), a California-based cannabis retailer that’s well-known for its sleek Apple Store-like retail locations across the United States, has finalized its reverse takeover and today is becoming one of the largest publicly-traded cannabis firms in the world.
The company is listing on the Canadian Securities Exchange, or CSE, following its reverse takeover of Ladera Ventures Corp. It is one of the first U.S. marijuana companies to list on the CSE. U.S. marijuana companies are currently barred from the TSX, Nasdaq and NYSE. The exposure on the CSE gives MedMen access to retail investors on a global scale and could fuel its already robust growth pattern.
Unique Experience
MedMen operates 12 licensed retail outlets in California, New York, and Nevada, including a 2,000 sq. ft. flagship store on New York City’s Fifth Avenue and another location on Santa Monica Boulevard in West Hollywood. In addition to dispensary operations, the company owns a 45,000 sq. ft. state of the art cultivation facility in Nevada and has broken ground on another in California to expand its cultivation operations.
CFN Media recently interviewed MedMen CEO Adam Bierman. Mr. Bierman discusses the reasons behind and the benefits of going public, along with the company’s potential going forward.
MedMen has taken the cannabis buying experience a long way from back-alley transactions just a few years ago. Its dispensaries are more akin to Apple Stores in terms of their bright and open architecture, as well as knowledgeable staff members in memorable red T-shirts. Management’s goal is to destigmatize cannabis and make mainstream adults feel comfortable purchasing product and carrying it out the door in the open.
“MedMen’s vision is simple but revolutionary: cannabis as a consumer product,” said MedMen Co-founder and CEO Adam Bierman. “For the better part of a decade we have been singularly focused on that vision – creating the systems and infrastructure that raise the bar on product quality and safety and providing a retail shopping experience that is second to none. By transitioning to a publicly-traded company, MedMen gives public investors a ground-floor opportunity to participate in the enormous and untapped potential of the fastest growing industry in the United States.”
MedMen Fifth Avenue
Growing Footprint
MedMen is primarily focused on acquiring top real estate to ensure that it will remain compliant with laws prohibiting locations close to schools, churches, or parks, as well as increase the reputability of its brand as a top-shelf option in major metro markets. The goal is to expand into these major markets as quickly as possible to build up a competitive edge against competitors that have been rolling out slowly in states like Colorado.
At the same time, the company recently partnered with Cronos Group Inc. (NASDAQ: CRON) to create a joint venture that will develop products and open MedMen-branded locations across Canada when recreational cannabis is legalized this summer. The move should help diversify operations and significantly increase revenue as it competes with the primarily mail-order industry that has built up in Canada around licensed producers.
Compelling Investment
With a pre-money valuation of $1.65 billion, MedMen could immediately become one of Canada’s ten largest cannabis companies and the most valuable U.S.-based cannabis company by market capitalization. The majority of the cannabis unicorns, or those companies with $1+ billion market capitalizations, are licensed producers of medical cannabis in Canada, including Canopy Growth Corp. (TSX: WEED) and Aurora Cannabis Inc. (TSX: ACB).
Investors may want to take a closer look at the stock given its unique reach into diverse U.S. markets and its focus on building a defensible national brand. At the same time, the company efforts to expand into Canada could unlock incremental value for shareholders following recreational legalization later this year.
MedMen Enterprises (CSE: MMEN) represents a compelling opportunity to invest in the cannabis industry. With its growing U.S. footprint, the company offers one of the only truly diversified plays on the U.S. cannabis industry. Meanwhile, its listing on the CSE ensures that investors across North America can easily acquire a piece of the company.
Disclaimer
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
About Ryan Allway
Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Rob is the co-founding President of Pelorus Equity Group and has more than 18 years of experience in the real estate finance industry. Since the formation of Pelorus in 2010, he has raised more than $175,000,000 in secured real estate transactions. Rob’s primary role at Pelorus Equity Group is the development of strategic alliances with […]
Silo Pharma is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research for people suffering from indications such as depression, PTSD, Parkinson’s, and other rare neurological disorders.
New You, Inc. (OTCQB: NWYU) wholly-owned subsidiary, ST Brands Corp is a holding company of branded assets that create, develop, market, and sell unique and proprietary cannabidiol (“CBD”) products to various segments of the global consumer market.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
